Full Text View
Tabular View
No Study Results Posted
Related Studies
An International Study of the Safety and Tolerability of Corlux for Psychotic Symptoms in Psychotic Major Depression
This study has been completed.
Study NCT00146523   Information provided by Corcept Therapeutics
First Received: September 2, 2005   Last Updated: February 22, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Major Depressive Disorder
Additional conditions recognized in this trial
Depression
Depressive Disorder
Depressive Disorder, Major
Psychotic Disorders
More general conditions related to this trial
Behavioral Symptoms
Mental Disorders
Mood Disorders
Schizophrenia and Disorders with Psychotic Features
Interventions listed in this trial
Mifepristone
More general drug interventions related to this trial
Abortifacient Agents
Abortifacient Agents, Steroidal
Contraceptive Agents
Contraceptive Agents, Female
Contraceptives, Oral
Contraceptives, Oral, Synthetic
Contraceptives, Postcoital
Contraceptives, Postcoital, Synthetic
Hormone Antagonists
Hormones, Hormone Substitutes, and Hormone Antagonists
Luteolytic Agents
Menstruation-Inducing Agents
Pharmacologic Actions
Physiological Effects of Drugs
Reproductive Control Agents
Therapeutic Uses
Sponsors listed in this trial
Corcept Therapeutics


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services